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Abstract
A chromosomal microdeletion at the 22q11.2 locus is associated with extensive cognitive impairments, schizophrenia and
other psychopathology in humans. Previous reports indicate that mouse models of the 22q11.2 microdeletion syndrome
(22q11.2DS) may model the genetic basis of cognitive deﬁcits relevant for neuropsychiatric disorders such as schizophrenia.
To assess the models usefulness for drug discovery, a novel mouse (Df(h22q11)/+) was assessed in an extensive battery of
cognitive assays by partners within the NEWMEDS collaboration (Innovative Medicines Initiative Grant Agreement No.
115008). This battery included classic and touchscreen-based paradigms with recognized sensitivity and multiple attempts
at reproducing previously published ﬁndings in 22q11.2DS mouse models. This work represents one of the most
comprehensive reports of cognitive functioning in a transgenic animal model. In accordance with previous reports, there
were non-signiﬁcant trends or marginal impairment in some tasks. However, the Df(h22q11)/+mouse did not show
comprehensive deﬁcits; no robust impairment was observed following more than 17 experiments and 14 behavioral
paradigms. Thus – within the current protocols – the 22q11.2DS mouse model fails to mimic the cognitive alterations
observed in human 22q11.2 deletion carriers. We suggest that the 22q11.2DS model may induce liability for cognitive
dysfunction with additional “hits” being required for phenotypic expression.
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Introduction
Hemizygous microdeletion at chromosomal locus 22q11.2 is a
copy number variation (CNV) that occurs in approximately
1:2000 births. It is associated with high incidence rates of cogni-
tive impairment and neuropsychiatric disorders, including
depression (Green et al. 2009), obsessive-compulsive disorder
(Gothelf et al. 2004), attentional-deﬁcit hyperactivity disorder
and autism (Niklasson et al. 2002). The deletion is the strongest
known genetic risk factor for schizophrenia with approximately
40% of carriers developing psychosis (Schneider et al. 2014).
Several genes within the deleted segment are involved in
cortical development (Maynard et al. 2003) and some 22q11.2
deletion syndrome (22q11.2DS) carriers exhibit structural aber-
rations within regions involved in higher-order cognitive func-
tioning such as the prefrontal cortex (PFC), hippocampus, and
dorsal striatum (Campbell et al. 2006) as well as disrupted
dopamine (DA) (Boot et al. 2007) and glutamate (da Silva Alves
et al. 2011) signaling. Some of these structural abnormalities
have also been reported in transgenic mouse models lacking
the orthologous chromosomal segment (Ellegood et al. 2014).
22q11.2DS is associated with extensive cognitive impair-
ments. 22q11.2DS is associated with mild to moderate re-
ductions in IQ-scores and learning impairments are observed in
85–100% of carriers (Lipson et al. 1991). Carriers can show deﬁcits
in cognitive domains such as visuospatial memory (Bearden
et al. 2001) working memory (Lajiness-O’Neill et al. 2005), atten-
tion (Bish et al. 2007) and cognitive ﬂexibility (Lewandowski
et al. 2006). Domain speciﬁc cognitive impairments also appear
to be independent of general intelligence (Shapiro et al. 2014).
Several transgenic mouse models of 22q11.2DS have been
created (Lindsay 2001) and cognitively phenotyped to varying
extents by different research groups. Most encompass the full
core region of the 22q11.1 deletion (Dgcr2-Hira), while others
carry partial deletions (Table 1). Schizophrenia-relevant sen-
sory and psychomotor behaviors have been reported as dis-
rupted in several of these models. The Df(16)A+/− mouse model
has been shown to display baseline hyperactivity and an
Table 1 Cognitive functioning in the Df(h22q11)/+mutant and other 22q11.2DS mouse models. ↓ impaired, ↑ improved, ╳ no effect, − no data.
Model Df(h22q11)/+ Df(16)A+/− LgDel Df1/+
Deletion Dgcr2-Hira Dgcr2-Hira Dgcr2-Hira Dgcr14-Ufd1l Znf74-Ctp
Strain C57/Bl6NTac C57/Bl6J C57/Bl6N Mixed C57/Bl6c-/c- ;
129S5/SvEvBrd
129SvEvTac or mixed
129SvEvTac ; Crl:NIHBL(S)
Behavior Paradigm
Memory Water maze <20 weeks ╳ − − ╳a −
Water maze >20 weeks ╳ ╳b − ↓a −
Contextual fear conditioning ╳ ↓c ╳d ↓e ╳f
TUNL – pattern separation ╳ − − − −
Auditory-cue fear conditioning ╳ ↓c ╳d ╳e ╳f
Touchscreen PAL ╳ − − − −
Novel object recognition ╳ ╳g − − −
Touchscreen discrimination
learning
“Easy” discrimination ↑ − − − −
“Difﬁcult” discrimination ╳ − ↓h − −
Working
Memory
Y-maze spontaneous alternation ╳ − − − −
TUNL – delay challenge ↑ − − − −
Radial arm-maze ╳ − − − −
T-maze non-match to sample
Acquisition ↓ ↓c ╳i − ↓j −
Delay challenge ╳ − − − −
Executive
function
PVT – Premature responses ╳ − − − −
5CSRTT – Premature responses ╳ − − − −
Touchscreen extinction learning ╳ − − − −
Touchscreen reversal learning
“Easy” reversal ↑ − − − −
“Difﬁcult” reversal ╳ − ↓h − −
Attention PVT – Reaction time ╳ − − − −
PVT – Correct responses ╳ − − − −
5-CSRTT – Accuracy ╳ − − − −
5-CSRTT – Omissions ↑ − − − −
aEarls et al. 2010.
bDrew et al. 2011.
cStark et al. 2008.
dLong et al. 2006.
ePaylor et al. 2001.
fKimber et al. 1999.
gFenelon et al. 2013.
hMeechan et al. 2015.
iSigurdsson et al. 2010.
jHughes et al. 2014.
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anxiogenic phenotype (Stark et al. 2008) while increased hyper-
activity in response to MK-801 was reported in the Df/+ model
(Kimoto et al. 2012). Similar to human carriers (Sobin et al.
2005) the Df(16)A+/−, Df1/+ and LgDel models displayed reduced
prepulse inhibition (Paylor et al. 2001; Long et al. 2006; Stark
et al. 2008) while the Df1/+ mutant had a increased acoustic
startle response (Paylor et al. 2001).
In earlier studies, learning and memory deﬁcits have
been reported in 22q11.2DS mouse models. The Df(16)A+/− and
Df(16)1+ mutants (Stark et al. 2008; Hughes et al. 2014) had
impaired spatial alternation learning in the T-maze although
the impairment has not always been replicated (Sigurdsson
et al. 2010). In the water maze, Df(16)1/+ mice (Earls et al. 2010)
but not the Df(16)A+/− mutant (Drew et al. 2011) showed age-
dependent impairments. Recently, the LgDel mutant was
shown to have improved early-phase reversal learning but
impaired late-phase and overall touchscreen reversal learning
as well as impaired discrimination performance (Meechan et al.
2015). The Df(16)A+/− and the Df1/+ models (Paylor et al. 2001;
Stark et al. 2008), but not the LgDel mouse (Long et al. 2006),
also showed impaired fear conditioning. Normal contextual
and auditory fear-conditioning was nevertheless observed in a
22q11.2DS model carrying a smaller 150 kB deletion (Kimber
et al. 1999).
Didriksen et al. describes the development and basic charac-
terization of a novel model of 22q11.2DS (Df(h22q11)/+) with a
hemizygous deletion at the region on mouse chromosome 16
that correspond to the core region of the human 22q11.2 dele-
tion (Didriksen et al. 2016). As expected, cortical mRNA expres-
sion of genes in the region is reduced approximately 50%. The
model shows deﬁcits in PPI and activity assays in response to
stimulants in the absence of overt baseline motoric deﬁcits,
making it suitable for screening in assays of cognition.
Following on such ﬁndings, the current set of experiments
investigated the extent and robustness of behavioral and cogni-
tive deﬁcits in this model with the ultimate aim of evaluating
its potential for cognitive translational studies. To this end,
four partners within the NEWMEDS collaboration (Innovative
Medicines Initiative Grant Agreement No. 115008) have pheno-
typed the Df(h22q11)/+ mouse using an extensive battery of
assays that depend on neural structures compromised in
22q.11.2DS and 22q.11.2DS mouse models (Ellegood et al. 2014).
The test battery contained several touchscreen assays that par-
allel the computerized tasks used with patients (Bussey et al.
2012; Hvoslef-Eide et al. 2015) and are sensitive to deﬁcits of
rodent models of neuropsychopathology (Bartko et al. 2010;
Brigman et al. 2010; Talpos et al. 2010; Graybeal et al. 2011;
Romberg et al. 2011; Nithianantharajah et al. 2012, 2015;
Gastambide et al. 2013; McAllister et al. 2013; Romberg et al.
2013; Kim et al. 2015). This represents the most extensive report
of cognitive functioning in a 22q11.2DS transgenic mouse model
to date (see Table 1).
Method
Animals
The generation of the Df(h22q11)/+ mouse is described in
Didriksen et al. (2016). Df(h22q11)/+ mice were of c57BL/6NTac
background. As 22q11.2DS models generated by others (Long
et al. 2006; Stark et al. 2008), the hemizygous deletion of the Df
(h22q11)/+ model extend between Dgcr2-Hira on mouse
chromosome 16 and encompass orthologs of all functional
genes on the critical human 22q11.2 locus with exception of
clathrin heavy polypeptide-like 1 (CLTCL) which appears absent
in the mouse genome (Botta et al. 1997). The mouse region also
includes Igll1 that is not part of the human region and has not
previously been linked to behavior or cognition in the mouse.
Transcriptional changes in the Df(h22q11)/+ model was con-
ﬁrmed by cortical RNAseq analysis and microarray analysis of
gene products from the deleted segment; detected products
were decreased to around 50% of the expression in WT mice
(Didriksen et al. 2016).
The experiments used 8 cohorts of animals. The age of ani-
mals at the start of each experiment and sample sizes for each
experiment are shown in Figure 1 and the legend of Figure 1,
respectively. Cohorts 1–5 and 8 consisted of male mice; cohorts
6–7 consisted of male and female mice. Animals were group-
housed (with the exception of Cohort 2 and 8 which were
single-housed prior to T-maze and radial arm maze experi-
ments) with ad libitum access to water under stable tempera-
ture and humidity conditions. Deﬁcits in acquisition of T-maze
delayed non-match to sample has previously been reported in a
Figure 1. Age at the start of each experiment of 8 cohorts of Df(h22q11)/+ and WT littermates. Cohort 1 was tested on the 5-CSRTT, PAL, Extinction (all WT N = 16,
TG N = 16) and T-maze (WT N = 10, TG N = 10). Cohort 2 was tested on reversal learning, TUNL, object recognition (all WT N = 16, TG N = 16) and T-maze (WT N = 11,
TG N = 14). Cohort 3 was tested in the Y-maze (WT N = 15, TG N = 16), automated T-maze (WT N = 13, TG N = 16) and the rPVT (WT N = 13, TG N = 16). Cohort 4
(WT N = 16, TG N = 16) and Cohort 5 (WT N = 10, TG N = 8) were tested in the water maze. Cohort 6 (WT N = 24, TG N = 24) was tested in auditory fear conditioning.
Cohort 7 (WT N = 20, TG N = 20) was tested on context-dependent fear conditioning. Cohort 8 (WT N = 16, TG N = 16) was tested in the radial-arm maze.
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single-housed 22q11.2DS mouse model. We therefore single-
housed Cohort 2 for 7 weeks prior to the T-maze experiment to
evaluate the role of housing condition in producing a phenotype
in this task. Prior to behavioral training, animals were food
deprived to about 85% of their free-feeding weight. Cohorts 1–2
and 8 were housed under a reversed 12 h light/dark cycle (lights
on at 7 p.m.). Cohorts 3–7 were housed under a standard 12 h
light/dark cycle (lights off at 7 p.m.). All studies were carried out
in accordance with European Union regulation (directive 2010/
63 of 22 September 2010), UK Animals (Scientiﬁc Procedures)
Act 1986 and UK Animals (Scientiﬁc Procedures) Act 1986
Amendment Regulations 2012, and were approved by the Danish
National Committee for Ethics in Animal Experimentation and
German Committee on Animal Care and Use.
Procedures
Attention and Behavioral Inhibition
Touchscreen 5-choice serial reaction time task (5-CSRTT). All touch-
screen assays were performed using 32 chambers (Campden
Instruments, Loughborough, UK) with associated software (Abet
II, Lafayette Instruments, Lafayette, IN, USA) described in detail
elsewhere (Mar et al. 2013). The 5-CSRTT measures attention and
impulsivity, cognitive domains disrupted in schizophrenia (Kahn
et al. 2012) and 22q11.2DS (Lewandowski et al. 2006). The task is
sensitive to attentional and impulsive disruptions in mouse mod-
els of neuropsychiatric disorders (Young et al. 2004; Hoyle et al.
2006; Romberg et al. 2011; Nilsson et al. 2016) and has been
described extensively elsewhere (Romberg et al. 2011; Mar et al.
2013). Brieﬂy, animals were trained to respond to a white-square
stimulus using a 2 s stimulus durations (SD), 40 trial session
length and 5 s delay. Once acquired, the animals were assessed
on a series of probe tests. This included tests of decreased SDs
(1.6, 1, 0.8, 0.6, 0.4, 0.2 s) increasing delays (7, 9, 11, 13 s) and tests
of increased session length (140 trials) with decreasing SDs (1.6, 1,
0.8, 0.6 s). The main dependent variables where percent accuracy,
percent omissions, percent premature responses, percent perse-
verative responses, correct response latency, and reward retrieval
latency.
Rodent psychomotor vigilance task (rPVT). The rPVT assesses
impulsive control and is described elsewhere (Gastambide et al.
2013). Task performance is sensitive to disruptions in rodent
models of schizophrenia (Gastambide et al. 2013). Brieﬂy, a trial
started with the illumination of the houselight (preparatory
cue) followed by a variable interval (VI5s; range: 4–6 s) and the
subsequent illumination of the magazine light for 10 s (impera-
tive cue). Head entries into the magazine during the imperative
cue were rewarded while head entries during the preparatory
cue were scored as premature and resulted in a 5 s time-out. To
assess impulsivity, probe-tests were performed at which length
of the interval between the imperative and preparatory cues
were extended from VI5s (range: 4–6 s) to VI10s (9–11 s) and
VI15 s (14–16 s). The main dependent variable was percent pre-
mature responses. The number of correct responses, omissions
and head entries, correct response latency and premature
response latency was also collected for each mouse.
Cognitive Flexibility
Touchscreen discrimination and reversal learning. Reversal learning
measures cognitive ﬂexibility which is disrupted in schizophre-
nia (Leeson et al. 2009) and 22q11.2DS (Lewandowski et al. 2006)
and the LgDel mouse model (Meechan et al. 2015). The task is
extensively described elsewhere (Horner et al. 2013; Mar et al.
2013). The task has been shown to be sensitive to transgenic
mouse models schizophrenia (Nithianantharajah et al. 2012) and
mouse PFC lesioning (Graybeal et al. 2011). Animals were tested
on two separate discrimination/reversals, the ﬁrst using more
discriminable stimuli and the second using more challenging
stimuli (see Fig 2i–l, insets). The criterion for successful discrim-
ination and reversal learning was ≥80% accuracy for two con-
secutive sessions. The dependent variables were trials to
criterion, errors to criterion, correction trials to criterion, average
correct response latency, and average reward retrieval latency.
During reversal learning, perseverative errors (the number
of incorrect responses made before achieving >50% correct
responding in session), learning errors (the number of incorrect
responses made after achieving ≤50% correct responses in a ses-
sion), and “perseveration index” (the number of correction trials
as a ratio of errors) (Brigman et al. 2010) were calculated.
Touchscreen extinction learning. Extinction of appetitive respond-
ing is dependent on the PFC, striatum and amygdala (Quirk and
Mueller 2007), areas disrupted in mouse models of 22q11.2DS
(Ellegood et al. 2014). The task is extensively described else-
where (Mar et al. 2013). In brief, animals were initially trained
to respond to a single-white square stimulus within 10 s for
reward. Animals were subsequently tested on extinction learn-
ing. During extinction learning, touches to the white-square
stimulus resulted in the removal of the stimulus in the absence
of rewards and conditioned reinforcers. The dependent vari-
ables were percent stimulus responses, response latency, and
blank touches (during the ITI when no stimulus was shown).
Working and Short-Term Memory
Touchscreen delayed non-match to location (rTUNL). The rTUNL task
measures working memory and pattern separation, which are
dependent upon the mPFC (McAllister et al. 2013) and hippo-
campus (Talpos et al. 2010). The rat version of the task is
described elsewhere (Oomen et al. 2013). Here we use a simpli-
ﬁed version of the task (Kim et al. 2015) (see Supplementary
Methods). Animals were tested on separate tests of increasing
delays (2, 4, 6, 8 s) and increasing stimuli separations (small,
large). To assess possible genotype differences in the use of
mediating strategies, animals were again tested on the 6 s delay
with sessions being video-recorded and behaviors during the
delay were scored and cost/beneﬁt scores were analyzed
(Talpos et al. 2010) using JWatcher (version 1.0). See supple-
mentary methods for detailed protocol.
T-maze delayed non-match to location. One cohort was assessed in
an automated version of the task (using 10, 30, 60 s delays).
Two further cohorts were assessed in a hand-run version of
the task using a protocol kindly shared by Joshua Gordon
(Columbia University) (Stark et al. 2008; Sigurdsson et al. 2010).
In the hand-run experiment, the ﬁrst cohort remained group-
housed while the second cohort was single-housed 7 weeks to
the beginning of training (Võikar et al. 2004). Other groups have
reported T-maze non-match to sample impairment in
22q11.2DS models using single-housed animals. The second
cohort was therefore single-housed to evaluate the role of
housing condition in a possible phenotype. See Supplementary
Methods for detailed protocol.
Y-maze spontaneous alternation. The task is sensitive to rodent
models of schizophrenia (Belforte et al. 2009) and is extensively
described elsewhere (Dillon et al. 2008). The sequence or arms
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entered was recoded and analyzed by Ethovision XT 8.5
(Noldus, Nottingham, UK) during a 15min session. The alterna-
tion rate was calculated as the number of alternations (e.g.,
ABC is an alternation, ABA is not) divided by the total number
of alternation opportunities (i.e., the total number of arm
entries minus two). The total distance traveled was also calcu-
lated for each mouse.
Radial-arm maze. The procedure is sensitive to mouse models of
schizophrenia and is extensively described elsewhere (Inta
et al. 2014). The main dependent variable was percent working
memory errors, calculated as the number of re-entries into bai-
ted arms as a ratio of the number of arm entries.
Long-Term Memory
Touchscreen paired-associate learning (PAL). The rPAL task mea-
sures visuospatial learning which is impaired in 22q11.2DS
(Bearden et al. 2001) and schizophrenia (Barnett et al. 2010).
The task is extensively described elsewhere (Horner et al. 2013).
In rats, performance is impaired by hippocampal (Talpos et al.
2009) and mPFC (McAllister et al. 2013) lesions. Robust learning
impairments in this task has been observed in an alternative
transgenic mouse model of schizophrenia (Nithianantharajah
Figure 2. Performance of Df(h22q11)/+ and WT littermates on touchscreen assays. Data is presented as means ± SEM (a–b) TUNL – delay challenge. The Df(h22q11)/+
showed higher accuracies (a) and required fewer correction trials (b) at longer delays. This effect was reproducible (see Supplementary Fig. S4d–e). (c–d) TUNL – separ-
ation challenge. No effects of genotype. (e–f) 5-CSRTT. No effect on accuracy (e). Following extensive training (>100) sessions the Df(h22q11)/+ showed a duration-
independent decrease in the number of omissions (f) when tested on 140-trial sessions. (g) PAL. No effects of genotype. (h) Extinction learning. No effect of genotype.
(i–l) Discrimination learning and reversal learning. In the initial easy discrimination (i) and reversal challenge (k), the Df(h22q11)/+ showed improved learning. In a
second more challenging discrimination (j) and reversal challenge (l) there were no effects of genotype. Insets depict the stimuli. Asterisk denote differences at which
p < 0 .05 (*p < 0.05, **p < 0.01, ***p < 0.001).
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et al. 2012). Animals were tested for 70 sessions and and the
data was collapsed in 5-session bins for analyses. The depend-
ent variables percent accuracy, correction trials, correct and
incorrect response latencies.
Fear-conditioning. Impaired contextual and auditory fear-
conditioning have been observed in a 22q11.2DS mouse model
(Stark et al. 2008). The task is extensively described elsewhere
(Medina et al. 2002).
Water maze. The procedure is extensive described elsewhere
(Podhorna and Didriksen 2005). Separate cohorts of 10-week
and 25-week old animals were tested with 4 and 6 acquisition
days, respectively, followed by a probe trial 24 h later. Data
were analyzed using Ethovision 3.0 (Noldus, Wageningen, The
Netherlands).
Novel object recognition. The task has been described previously
(Winters et al. 2008). Animals were tested on 3, 8, 14, and 24 h
delays. Video analyses of behavior were made by an experi-
menter blind to the genotype and location of the novel object
using JWatcher (version 1.0). For each animal, the discrimin-
ation ratio (time spent exploring the novel object divided by the
total time spent exploring), object exploration time in the
sample-phase, and object biases were calculated.
Statistical Analyses
Data was analyzed through one-way ANOVA with genotype as
between-subjects variable or repeated-measures ANOVA with
genotype (and sex, where appropriate) as between-subject vari-
able(s) and session, delay, stimulus duration, learning phase or
stimulus separation as the within-subjects variable. Signiﬁcant
interactions where followed by one-way ANOVA. See Result for
experiment-speciﬁc information. Analyses were done using
SPSS (v21.0, IBM Corp, Armonk, NY).
Results
See Table 1 for a summary of the results in the complete
test battery. See Table S1 for overall average response latencies
and reward retrieval latencies during touchscreen cognitive tests.
Attention and Behavioral Inhibition
5-CSRTT
The data was analyzed by mixed model ANOVAs. In short ses-
sions with decreasing SDs (Fig. S1a–b) there was no effect of
genotype on accuracy (genotype: F1,30 = 0.240, p = 0.877;
genotype × SD: F6,180 = 1.141, p = 0.340) or omissions (genotype:
F1,30 = 0.235, p = 0.631; genotype × SD: F6,180 = 0.591, p = 0.737).
There were no effects of genotype or genotype × SD interaction
on any other behavioral measure (all p ≥ 0.193). When increas-
ing the delay, there was no effect of genotype on premature
responses (Fig. S1c; genotype: F1,30 = 0.240, p = 0.878;
genotype × SD; F4,120 = 1.102, p = 0.359). There were no other
effects of genotype or genotype × SD interactions (all p ≥ 0.055).
Tests on long sessions (140 trials) following extensive training
(>100 session) showed an improved performance in the Df
(h22q11)/+ with the transgenic making fewer omissions
(Fig. 2e–f; genotype: F1,30 = 12.134, p = 0.002). On response laten-
cies, there was a genotype × SD interaction (F3,90 = 6.467,
p < 0.001) with Df(h22q11)/+ animals showing faster responses
at the 2 s SD (F1,30 = 5.384, p = 0.027; data not shown). There
were no other effects of genotype or genotype × SD interactions
(all p ≥ 0.287).
Rodent Psychomotor Vigilance Task
There was no effect of genotype on premature responses dur-
ing task acquisition (Fig. S2a–c; Mixed model ANOVA, effect of
genotype: F1,27 = 0.483, p = 0.493; interaction effect geno-
type × session F6,162 = 0.703, p = 0.648). There were no effects of
genotype on accuracy, omissions or average correct response
latencies (Mixed model ANOVA or between-subject ANOVA, all
p ≥ 0.333). Increasing the variable interval revealed a non-
signiﬁcant trend for the Df(h22q11)/+ mutant to make more
premature responses than the WT (Fig. 3g; Mixed model
ANOVA, effect of genotype: F2,54 = 3.805, p = 0.062; interaction
effect genotype × interval: F2,54 = 0.375, p = 0.689).
Learning and Cognitive Flexibility
Visual Discrimination and Reversal Learning
The data was analyzed by one-way between-subjects ANOVAs.
In the ﬁrst discrimination, the Df(h22q11)/+ mice required few-
er trials (Fig. 2i; F1,30 = 4.793, p = 0.036) and made fewer incor-
rect responses (F1,30 = 6.101, p = 0.019). Genotype did not affect
correction trials or latency measures (all p ≥ 0.345). In the ﬁrst
reversal (Fig. 2k), the mutant required fewer trials (F1,30 = 11.769,
p = 0.002) and incorrect responses to criterion (F1,30 = 9.771,
p = 0.004). Df(h22q11)/+ mice made fewer late errors
(F1,30 = 12.556, p = 0.001) but not early errors (F1,30 = 0.98,
p = 0.757). Again, genotype failed to affect correction trials and
latency measures (all p ≥ 0.172). A second test using less discrim-
inable stimuli showed no effect of genotype on discrimination
(Fig. 2j) or reversal learning (Fig. 2l; all p ≥ 0.127).
Extinction Learning
Genotype did not affect extinction learning (Fig. 2h; Mixed mod-
el ANOVA, effect of genotype: F9,270 = 0.118, p = 0.734; inter-
action effect genotype × session: F9,270 = 1.820, p = 0.065).
Working and Short-Term Memory
Water Maze
In 10-week old animals (Fig. 3e–f), there was no effect of geno-
type on acquisition (Mixed model ANOVA, effect of genotype:
F1,30 = 2.763, p = 0.107; interaction effect genotype × session:
F3,90 = 0.856, p = 0.467) or delay-probe (Between-subjects
ANOVA, F1,30 = 1.754, p = 0.195). There was also no effect of
genotype in 25-week old animals (Fig. S4a–b. all p ≥ 0.180).
Y-maze Spontaneous Alternation
There was no effect of genotype on alternation rate (Fig. 3h;
Between-subjects ANOVA, F1,29 = 2.869, p = 0.101).
Radial-arm Maze
There was no effect of genotype on working memory errors
over 10 test session (Fig. 3k; Mixed model ANOVA, effect of
genotype: F1,30 = 0.282, p = 0.599; interaction effect geno-
type × session: F9,270 = 0.740, p = 0.672).
Trial-unique Non-match to Sample
The Df(h22q11)/+ showed higher accuracies relative to the WT
when manipulating the delay (Fig. 2a; Mixed model ANOVA,
effect of genotype: F1,30 = 5.567, p = 0.025; interaction effect
genotype × delay: F3,90 = 1.090, p = 0.357). Df(h22q11)/+ mice
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required fewer correction trials (Fig. 2b; Mixed model ANOVA,
interaction effect genotype × delay: F3,90 = 4.094, p = 0.009) at
the 6 s and 8 s delays (Between-subjects ANOVAs, p ≤ 0.017).
Tests of pattern separation showed no effect of genotype
(Fig. 2c–d; all p ≥ 0.832). In video analyses of mediating beha-
viors, Df(h22q11)/+ mice again outperformed WTs at the 6 s
delay (Fig. S4d–e; Mixed model ANOVA, effect of genotype on
accuracy: F1,30 = 4.879, p = 0.035; correction trials: F1,30 = 7.879,
p = 0.009). There were no genotype differences in cost/beneﬁt
scores for any behavior (Fig. S3).
T-maze Delayed Non-match to Location
There was no effect of housing-condition on performance (all
p ≥ 0.509) and groups were collapsed for analyses. In acquisi-
tion, the Df(h22q11)/+ mouse showed slower learning relative
to the WT (Fig. 3a; Between-subjects ANOVA, effect of geno-
type: F1,43 = 4.579, p = 0.038). Genotype did not affect perform-
ance in tests of 10 s, 60 s, 120 s, and 240 s delays (Fig. 3b; Mixed
model ANOVA, effect of genotype: F1,43 = 1.719, p = 0.197; inter-
action effect genotype × delay: F3,129 = 0.864, p = 0.462). Further
tests using 10 s and 90 s delays revealed no genotype
Figure 3. Performance of Df(h22q11)/+ and WT littermates on non-touchscreen assays. Data is presented as means ± SEM. (a–b) Hand-run T-maze. Df(h22q11)/+mice
required more sessions to acquire T-maze alternation criterion (a). No effect of genotype on tests of variable delays (b). Broken line represents random responding. (c)
Automated T-maze. No effects of genotype. (d) Novel object recognition. No effects of genotype. (e–f) Water maze. No signiﬁcant genotype differences in 10-week old
animals on task acquisition (e) or a 24 h probe test (f). No effects were observed in 10-week old animals (see Supplementary Fig. S4a-b). (g) Psychomotor vigilance task.
No effect of genotype on probe-tests of impulsive-like behavior. (h) Y-maze. No effects of genotype. Broken line represents random responding. (i) Auditory fear condi-
tioning. No effect of genotype (j) Context-dependent fear conditioning. No effect of genotype. (k) Radial arm-maze. No effect of genotype. Asterisk denote differences
at which p < 0.05.
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differences (Fig. S4c). There were no effects of genotype in the
automated T-maze task (Fig. 3c; all p ≥ 0.372).
Fear-conditioning
The data was analyzed by mixed model ANOVAs. In the audi-
tory cue condition, there were no effects of genotype on freez-
ing (Fig. 3i; genotype, pre-CS: F1,46 = 0.405, p = 0.528; CS:
F1,46 = 2.046, p = 0.159). Males were more immobile than
females (data not shown; sex, Pre-CS: F1,46 = 5.835, p = 0.020;
CS: F1,46 = 4.501, p = 0.039). Separate analyses by sex showed
no effect of genotype (p ≥ 0.280). In the context condition,
there were no effects of genotype (Fig. 3j; F1,38 = 0.975,
p = 0.330) or sex (F1,38 = 1.904, p = 0.176).
Long-Term Memory
Paired Associate Learning
Data was analyzed by mixed model ANOVAs. There was no
effect of genotype on accuracy (Fig. 2g; genotype: F1,26 = 0.679,
p = 0.417; genotype × session: F13,338 = 0.481 p = 0.935), correc-
tion trials (genotype: F1,26 = 0.236, p = 0.631; genotype × session:
F13,390 = 0.528 p = 0.907; data not shown) or latency measures
(p ≥ 0.406).
Novel Object Recognition
Genotype had no effect on novel object recognition at any delay
(Fig. 3d; Mixed model ANOVA, effect of genotype: F1,24 = 0.244,
p = 0.625; interaction effect genotype × delay: F3,72 = 0.057,
p = 0.982).
Discussion
This report represents a multi-site evaluation of cognitive func-
tioning in a 22q11.2DS mouse model by several partners in the
NEWMEDS collaboration. It is the most comprehensive evalu-
ation of cognition in a 22q11.2DS mouse model to date
(Table 1). We selected a set of behavioral tests that have been
shown to be sensitive to manipulations relevant for the
22q11.2DS and schizophrenia. These assays each evaluates
individually distinct yet on a broader level partially overlapping
cognitive functions and have demonstrated sensitivity to
manipulations of PFC, hippocampal, DA and glutamate sys-
tems, as well as transgenic mouse models of neuropsychiatric
disorders, including schizophrenia (Brigman et al. 2008;
Winters et al. 2008; Talpos et al. 2009, 2010; Graybeal et al. 2011;
Nithianantharajah et al. 2012; Gastambide et al. 2013;
McAllister et al. 2013).
We found that the Df(h22q11)/+ mutant, in agreement with
previous reports on 22q11.2DS models, shows impairments
or trends towards impairments in several behavioral assays
relevant to the cognitive impairments of neuropsychiatric dis-
orders. This includes a deﬁcit in acquisition of a T-maze non-
match-to-sample task as well as non-signiﬁcant trends towards
impaired spatial memory in the Y-maze and water maze. The
Df(h22q11)/+ mouse also showed trends towards increased
impulsive responding in the psychomotor vigilance task and
impaired auditory cue fear-conditioning.
However, the Df(h22q11)/+ mice showed normal performance
in a range of other assays. This includes normal performance on
object recognition, paired-associates learning, extinction learning,
and contextual fear-conditioning. Improved performance was
observed on cognitive ﬂexibility (reversal learning), attention
(5-CSRTT), and touchscreen spatial working memory (TUNL). In
sum, although the Df(h22q11)/+mouse model has been shown to
recapitulate certain sensory and psychomotor phenotypes with
relevance for schizophrenia (Didriksen et al. 2016), and minor
cognitive deﬁcits were observed in this study, it fails to mimic the
extent of cognitive impairment observed in human 22q11.2 dele-
tion carriers and schizophrenia patients. Considering possible
reasons for the apparent mismatch between the CNS changes
and the broad lack of behavioral effects, it is most unlikely that it
results from a lack of statistical power or sensitivity of the behav-
ioral assays, as these assays have revealed deﬁcits using other
lines of genetically modiﬁed mice (Brigman et al. 2008, 2010;
Bartko et al. 2011; Romberg et al. 2011; Barkus et al. 2012; Coba
et al. 2012; Nithianantharajah et al. 2012; Ryan et al. 2012;
Romberg et al. 2013; Nithianantharajah et al. 2015). It remains
possible that functional compensatory changes protect the ani-
mals from critical neuronalmolecular effects and profound cogni-
tive impairments. Such compensation is not obviously present in
22q11.2DS and schizophrenia patients. On the other hand, it is
also possible that the neurobiological changes seen in the model
are insufﬁcient to produce profound deﬁcits. It is important to
keep in mind that the 22q11.2 microdeletion has incomplete
penetrance in humans and syndrome expression presumably
depends on the complete genetic makeup in concert with envir-
onmental inﬂuences. Thus, the Df(h22q11)/+ mouse may more
appropriately be thought of as a liability model rather than a dis-
ease model.
Earlier studies indicate that 22q11.2DS models with overlap-
ping heterozygote deletions showed impaired (Stark et al. 2008;
Hughes et al. 2014) or trends towards impaired (Sigurdsson
et al. 2010) spatial learning in the T-maze. In agreement with
these earlier studies, we saw impaired acquisition learning in
this task. This mild effect was transient, however; when mice
were subsequently tested on the same delay used during acqui-
sition, there was no impairment. Furthermore, the impairment
could not be re-instated by challenging the animals further
with longer delays. The ability of Df(h22q11)/+ mice to perform
well on longer delays suggests that these animals do not have
a working memory impairment per se; instead the initial mild
deﬁcit, which was present on day one of testing, may be more
related to the propensity of animals to non-match, or other
nonspeciﬁc performance factors. There were no signiﬁcant
effects of genotype in the automated version of the task. The
data therefore do not convincingly support that the Df(h22q11)/+
mouse combined with T-maze testing might serve as a useful
model for assessing the effects of cognitive enhancing drugs on
working memory.
We observed trends toward impairments in auditory fear-
conditioning and in the water maze when tested at 10 and
25 weeks of age. Previous studies of 22q11.2DS models have
reported inconsistent results in these tasks. The Df(16)A+/− and
Df1/+ mice (Paylor et al. 2001; Stark et al. 2008) had deﬁcits in
contextual fear-conditioning following a 24h delay. The Df(16)A+/−
mouse (Stark et al. 2008) also showed reduced auditory fear-
conditioning. However, the Df1/+ mouse had normal auditory
fear-conditioning and normal contextual fear-conditioning using
a 1h delay (Paylor et al. 2001). Similarly, no auditory or contextual
fear conditioning deﬁcits were present in the LgDel mouse (Long
et al. 2006) or in mice with the smaller Znf74-Ctp deletion (Kimber
et al. 1999). In the water-maze, 16–20 weeks old Df(16)1/+mice but
not 6–8 week old Df(16)1/+ mice showed spatial learning deﬁcits
(Earls et al. 2010) and no impairment was observed in Df(16)A+/−
mutants at 5–7 months of age (Drew et al. 2011).
The Df(h22q11)/+ mutant showed improved discrimination
and reversal learning when challenged with an easily discrim-
inable stimulus pair, yet no effect of genotype was observed
when tested using a less discriminable stimulus pair. In con-
trast, the LgDel mouse was shown to display impaired touchsc-
reen discrimination and reversal learning (Meechan et al. 2015).
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Meechan et al. (2015) observed large performance variability in
their LgDel mutants relative to WT animals. Here, many trans-
genic animals displayed behavior comparable to WTs and the
overall impairment on reversal learning appeared driven by a
subgroup of mutants. There are as yet no reports of such het-
erogeneity in the Df(16)1/+ , Df(16)A+/− or Df1/+ mutants, and
we did not observe it in Df(h22q11)/+ mice. Furthermore,
although the LgDel mouse showed an increase in overall incor-
rect responses, the mutant also showed a decrease in early
perseverative-like errors, most relevant for modeling prefrontal
dysfunction and cognitive inﬂexibility impairment of psychi-
atric disorders, including schizophrenia (Iversen and Michkin
1970; Elliott et al. 1995; Dias et al. 1996). Other factors that may
explain the contrasting behavioral phenotypes of the LgDel
and Df(h22q11)/+ models (or other behavioral discrepancies
observed across laboratories in the independently generated
22q11.2DS mouse models) include the different background
strains, ages, sex, and possible protocol differences, including
the use of different stimuli, housing conditions and training
protocols.
The Df(h22q11)/+ mouse also showed improved perform-
ance in the TUNL test of working memory and the 5-CSRTT test
of attention (following extensive training). A tentative sugges-
tion is that these effects may be produced by COMT haploinsuf-
ﬁency. Cognitive abilities are related to a PFC-DA inverted-U
curve whereby low levels of increased stimulation at the D1
receptor can improve performance (Kroener et al. 2009). In both
humans and rodents, COMT inhibition can improve cognitive
ﬂexibility, attention, and working memory (Tunbridge 2004;
Lapish et al. 2008). Decreased COMT activity through the COMT
val108/158 allele has been associated with elevated cortical DA
(Lachman et al. 1996), improved cognitive ﬂexibility (Malhotra
et al. 2002), working memory and attention (Blasi 2005; Caldú
et al. 2007). COMT heterozygous mice have shown increased
PFC-DA levels (Gogos et al. 1998), improved attentional set-
shifting (Scheggia et al. 2014) and working memory (Papaleo
et al. 2008). Elevated PFC-DOPAC is also observed in the Df
(h22q11)/+ mouse (Didriksen et al. 2016). Mouse and human
COMT orthologs also show radical differences in enzymatic
activity (Chen et al. 2004) which may be related the divergent
cognitive phenotypes of 22q11.2 deletion carriers and the Df
(h22q11)/+ mouse. Thus, improved performance on tests of
executive functioning in the Df(h22q11)/+ mutant as well as
the lack of effect of genotype in many assays could be related
to COMT heterozygosity and increased PFC-DA levels oversha-
dowing putative detrimental effects of further allelic insufﬁ-
ciencies on cognition in this model.
The 22q11DS Mouse Model as a Translational Tool for
Psychiatric Drug Discovery
Being the strongest known genetic risk factor for schizophrenia,
the 22q11.2DS is of considerable interest for translational
research as it may allow for a model with good construct valid-
ity when probing the genetic basis of schizophrenia-relevant
cognitive impairments. Our ﬁndings nevertheless suggest that
deletion of the relevant chromosomal segment in the mouse
confer a mild phenotype that fails to mimic the extent of the
human cognitive impairment. There are differences within the
orthologous regions in mice (MMU16) and humans (22q11.2)
that may be involved in the lack of translation of the complete
cognitive phenotype. This includes several genomic rearrange-
ments in 22q11.2 segment relative to the mouse MMU16, and
the low-copy repeats of the 22q11.2 region thought to infer seg-
ment instability is absent on the rodent MMU16 (Botta et al.
1997). The mouse do not carry a CLTCL ortholog for which
hemizygosity has been linked to some primarily non-cognitive
22q11.2DS phenotypes (Sirotkin et al. 1996; Holmes et al. 1997).
Mouse and human COMT orthologues also differ in enzymatic
activity (Chen et al. 2004). Furthermore, in other constitutive
mouse models of schizophrenia, haploinsufﬁciency can be
insufﬁcient in producing cognitive phenotypes of the disorders
and homozygous mutants have been required
(Nithianantharajah and Grant 2013). Homozygous 22q11.2DS
mouse models are, however, unfortunately not presently
viable. As stated above, the 22q11.2DS model may also be con-
sidered a liability model. Thus a more pronounced phenotype
might appear in other assay conditions or in combination with
additional environmental risk factors. For example, pubertal
stress revealed latent neuropathological consequences of pre-
natal immune activation, another risk factor for schizophrenia
(Giovanoli et al. 2013). It may be that a similar approach is
necessary for unmasking robust dysfunctions in the 22q11.2DS
mouse model and other CNV models (Kogan et al. 2015; Nilsson
et al. 2016) where phenotypic expression within multiple
domains of cognition can remain below threshold.
Yet it should be noted that current study is not a complete
assessment of 22q11.2DS-relevant cognitive functions. For
example, 22q11.2DS is associated with deﬁcits in visual sus-
tained attention as measured by Go/no-go or continuous per-
formance tasks (Lewandowski et al. 2006; Antshel et al. 2010;
Shashi et al. 2010, 2012; Hooper et al. 2013; Schoch et al. 2014).
Several 22q11.2DS mouse models (Kimber et al. 1999; Paylor
et al. 2001; Long et al. 2006; Stark et al. 2008), including the Df
(h22q11)/+ mutant (Didriksen et al. 2016), also show sensori-
motor gating deﬁcits, considered a marker of pre-attentative
information processing (Powell et al. 2009). Although the cur-
rent battery did not include tests of visual sustained attention
or motivational functioning, the demonstrated link between
these domains and 22q11.2DS may warrant further behavioral
study in the Df(h22q11)/+mouse.
Conclusion
In agreement with the previous literature, the mouse model of
22q11.2DS showed some impairments or trends towards
impairments in tasks of cognition. However, this extensive test
battery indicates that the model does not mimic the extent of
22q11.2DS-related cognitive deﬁcits as seen in affected human
carriers. It may be that functional compensations protect the
animals from profound cognitive deﬁcits or that the genetic
changes observed in this mutant are insufﬁcient to produce
major behavioral impairments unless they are exposed to add-
itional risk factors. Possibilities remain that tests not included
in the current study are sensitive to the genetic disruptions of
the 22q.11.2DS model.
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Supplementary material can be found at: http://www.cercor.
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